Drawing for HALIODX

USPTO serial 79188392

HALIODX

Reviewed by CopyMark Law Group

Reg. 5435316Status 404
Filing date
Status date
Registration date
Apr 3, 2018
Examiner
RICHARDS, LESLIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HALIODX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cathleen E. Stadecker

Cathleen E. Stadecker Downs Rachlin Martin PLLC199 Main Street, P.O. Box 190Burlington, VT 05402-0190UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for use in vitro testing for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; chemical preparations for medical and pharmaceutical use for in vitro testing for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; biological reagents for medical use for providing information on diagnostics or identification of biological systems, namely, diagnosis or prognosis of cancer and assessment of patient's response to anti-cancer treatment, monitoring and management of anti-cancer treatment; biological reagents for providing information on diagnostics or identification of biological systems, namely, diagnosis or prognosis of cancer and assessment of patient's response to anti-cancer treatment, monitoring and management of anti-cancer treatmentSECTION 71 - CANCELLED—
009Downloadable computer software for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; downloadable software in the nature of a mobile application for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical conditionSECTION 71 - CANCELLED—
010Medical apparatus and instruments, namely, autostainers, scanners, medical testing devices and diagnostic apparatus for detecting, analyzing or assessing a cancer, tumor or equivalent medical conditionSECTION 71 - CANCELLED—
044Medical analysis services, namely, in vitro testing services for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; health assessment services; genetic testing for medical purposes, namely, in vitro testing services for use in the clinical diagnostic and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical conditionSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 17, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 30, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Nov 11, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 11, 2025INPCINVALIDATION PROCESSED—
Aug 21, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 18, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 18, 2024C71TCANCELLED SECTION 71—
Apr 3, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 12, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 25, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 11, 2018CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Oct 11, 2018CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Aug 31, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Aug 31, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Aug 3, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 10, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 10, 2018FIMPFINAL DISPOSITION PROCESSED—
Jul 3, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 3, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 3, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jan 18, 2018OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 16, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 27, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 27, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 27, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 13, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 13, 2017OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 6, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 5, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Dec 5, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 5, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 5, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 6, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 6, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 6, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 27, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 26, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 23, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2017DOCKASSIGNED TO EXAMINER—
Feb 1, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 1, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 26, 2017ALIEASSIGNED TO LIE—
Jan 9, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 9, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 9, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 5, 2017CHLDCHANGE OF OWNER RECEIVED FROM IB—
Dec 22, 2016ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 29, 2016RFNTREFUSAL PROCESSED BY IB—
Jul 12, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 11, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 11, 2016RFRRREFUSAL PROCESSED BY MPU—
Jul 10, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 9, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2016DOCKASSIGNED TO EXAMINER—
Jul 8, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 7, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance